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Childhood neurodevelopmental disorders include autistic spectrum disorder (ASD), attention 
deficit/hyperactivity disorder (ADHD), communication disorders, learning disabilities and 
developmental motor-co-ordination problems among others (1). These conditions typically are 
considered to  originate early in development, although there have been recent, controversial 
challenges to this assumption for ADHD (2). Childhood neurodevelopmental disorders, regardless of 
whether they are defined as diagnostic categories or traits, show strong phenotypic and genetic 
overlaps with each other(1). It is also well known that autism can be preceded by very early motor 
and sensory developmental problems (3) such as motor “floppiness”, delayed motor milestones and 
hypersensitivity to sensory stimuli.  These are non-specific markers of atypical development because 
they may also index global developmental delay and predate other disorders including 
schizophrenia(4) and ADHD (3). However, these early indicators of atypical development are 
sometimes overlooked in the psychiatric literature.  
In this issue of Biological Psychiatry, Serdarevic and colleagues(5) address this important gap in 
Generation R, a prospective, population-based cohort from Rotterdam in the Netherlands; they use 
data from almost 2000 individuals of European ancestry. The authors directly examine neuromotor 
development in infants aged 9 to 20 months and subsequently assess autistic traits in these children 
at age 6, using a parent-reported questionnaire. The authors are to be commended because the 
neuromotor assessment was conducted directly with the infant at home using a modified version of 
the Touwen’s Neurodevelopmental Examination. This provides a very different measure to the ones 
typically used in Psychiatry that rely on reported symptoms. The authors then derived a construct 
called “neuromotor development” that consisted of different sub-scales including high and low 
muscle tone, infant responses and a wide variety of other observations such as startle and eye 
fixation. Their aim was to test whether ASD and ADHD genetic liability is associated with suboptimal 
infant motor and sensory development. This was achieved using two methods: first, by testing 
association between ADHD and ASD polygenic risk scores (PRS) and neuromotor development and 
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second, by assessing SNP co-heritability between ASD and motor development (using GREML: the 
genomic-relatedness-based restricted maximum-likelihood approach)(6). 
Polygenic risk scores (PRS) are a composite measure of “risk” alleles (7) identified from an 
independent, discovery genome-wide association (GWAS) data set. They have been found to provide 
useful indicators of disease risk but are only weakly predictive.   
As might be expected, given that ADHD and ASD diagnoses show genetic correlation (8), both ASD 
and ADHD PRS were observed to be associated with ASD traits at age 6 years (boys only for ADHD 
PRS). The novel finding is that ASD PRS was also associated with directly assessed overall infant 
neuromotor functioning. In terms of specific sub-scale outcomes: ASD PRS were associated with low 
muscle tone and high ADHD PRS were associated with lower scores on the measure of “senses and 
other observations”. Associations were most consistent in boys.  Using the SNP-based heritability 
approach, both autistic traits and motor development were observed to be heritable and the 
authors observed a moderate genetic correlation of 0.32 (SE=0.17) between overall motor tone and 
autistic traits.  
 
The strengths of this paper are that it utilizes a prospective, population-based cohort design and 
therefore avoids clinical referral selection and infant development is assessed directly. The authors 
also focus on an important developmental period. The limitations, many of which are highlighted by 
the authors, include the current weak predictive power of ASD and ADHD PRS and the inconsistency 
of findings across different p-value thresholds for ADHD and ASD PRS.  Also, it is worth highlighting 
that SNP heritability, unlike twin heritability captures only a small component of genetic variation. 
Another problem that the authors encountered is a global concern (9).  At present, GWAS data lack 
diversity and overwhelmingly represent individuals of European descent. This means that the 
authors were forced to restrict their analyses to those of European ancestry even though the full 
Generation R cohort is ethnically diverse. Another issue to consider is that ASD is examined as a trait 
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not as a diagnosis measure in this population-based cohort. However there is growing evidence from 
the perspective of genetics at least that there is genetic overlap between ASD traits and disorder 
(10).  As data on ASD or ADHD traits prior to the age of 6 years are not presented, it is intriguing as 
to whether the early developmental problems genuinely precede the emergence of core ASD 
features. 
 
What do the findings mean? First, they suggest that the same genetic liability which contributes to 
ASD also indexes sub-optimal infant motor development. Genetic correlations between different 
neurodevelopmental and neuropsychiatric disorders are now well established. The findings of this 
study highlight additional genetic overlap between childhood neurodevelopmental disorders and 
early neuromotor and sensory development. These findings concur with those emerging from high-
risk studies of infants at elevated familial risk for autism(3). Those investigations also suggest that 
familial/genetic liability is indexed by very early developmental signs in infancy. What is important to 
know is whether these are causal antecedents, disorder precursors or simply developmental 
accompaniments to ASD. 
 
Most individuals with sub-optimal motor and sensory development in the general population will 
not necessarily go onto develop a full-blown clinical diagnosis of autism. Thus, some important 
clinical questions remain. What influences the transition from impaired neuromotor development to 
the complete manifestation of autism? Can the underlying biological processes and developmental 
trajectory be altered or are the early developmental manifestations simply an initial signpost of 
underlying genetic liability and the developmental processes underlying the emergence of autism 
will unfold regardless?  The findings of this study further raise the practical issue of whether regular 
screening for ASD (and other neurodevelopmental disorders) is warranted in all infants who show 
sub-optimal development. This clearly would require evaluation. As is often the case with any 
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interesting study, the findings highlight the need for replication and extension, additional 
hypotheses to test, and a series of important questions to resolve in the future.  
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Figure 1 
ASD genetic liability association with infant neuromotor development and ASD traits at age 6 
years  
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